Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...

Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and ...

Scientists have uncovered a blood-based molecular signature that can predict vaccine durability. Could this change ...

The UBC team's research, published this week in the journal Nature Communications, dubbed the highly-specialized neurons 'ovoid cells.' ...

Scientists at the University of São Paulo analysed blood samples donated by six serodiscordant couples – the situation one ...

Jackery's latest LiFePO4 power station is remarkably robust and highly portable. With the Explorer 2000 v2, the leading provider of portable energy solutions introduces the lightest and most compact ...

Blueprint Medicines Corp (NASDAQ:BPMC) reported a challenging fourth quarter for 2024, missing analyst expectations for both earnings per share (EPS) and revenue. The company posted an EPS of -0.79, ...

Innovaccer Inc. today announced it has improved its integration with athenahealth through the company's Marketplace program, making it easier for joint customers to access important analytics while ...

This Press Release updates numerical list in reference sectionTheralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the treatment of th ...